Independent Advisor Alliance’s ADMA Biologics ADMA Stock Holding History

Independent Advisor Alliance’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-109,584	Closed	-$1.61M	–	1000
2025 Q3	$1.61M	Sell	109,584 -5,979	-5%	-$102K	0.04%	343
2025 Q2	$2.1M	Buy	115,563 +26,088	+29%	+$532K	0.06%	265
2025 Q1	$1.78M	Buy	+89,475	New	+$1.55M	0.06%	270
2023 Q2	–	Sell	-10,193	Closed	-$33.7K	–	669
2023 Q1	$33.7K	Hold	10,193	–	–	﹤0.01%	650
2022 Q4	$40	Hold	10,193	–	–	﹤0.01%	404
2022 Q3	$25K	Hold	10,193	–	–	﹤0.01%	616
2022 Q2	$20K	Hold	10,193	–	–	﹤0.01%	609
2022 Q1	$19K	Hold	10,193	–	–	﹤0.01%	654
2021 Q4	$14K	Hold	10,193	–	–	﹤0.01%	670
2021 Q3	$12K	Buy	+10,193	New	+$14.3K	﹤0.01%	630
2021 Q1	–	Sell	-10,193	Closed	-$20K	–	593
2020 Q4	$20K	Buy	+10,193	New	+$21.4K	﹤0.01%	547

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Independent Advisor Alliance's ADMA Position: Q4 2025 in Review

Independent Advisor Alliance sold out of ADMA Biologics (ADMA) in Q4 2025, closing a stake of 109,584 shares — an estimated $1.61M sold.

Independent Advisor Alliance first reported a position in ADMA in Q4 2020 and held it in 11 quarters. The position peaked at $2.1M in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

Independent Advisor Alliance reported no remaining ADMA Biologics position as of Q4 2025 after selling out during the quarter.
Independent Advisor Alliance sold 109,584 ADMA Biologics shares in Q4 2025, an estimated $1.61M.
Independent Advisor Alliance first reported a position in ADMA Biologics in Q4 2020 and held it in 11 quarters.
Independent Advisor Alliance's ADMA Biologics position peaked at $2.1M in Q2 2025.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on Independent Advisor Alliance's 13F filing for Q4 2025, filed 4 Feb 2026.